NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
Clinical Trials
3 trialsNCT00118040 2021-06-10
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00001696 2008-03-04
A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
National Institutes of Health Clinical Center (CC)
Phase 1 Completed